Biotech IPOs: Lessons on How a Company Manages to Succeed After Failure


The following post was published on the Knowledge@Wharton website on January 22, 2014. The data is in, and there is no question that 2013 was the most active year for biotechnology initial public...

Intercept Pharma Continues Epic Stock Surge After Thursday Blockbuster


Fresh off Thursday’s amazing 280% stock pop, Intercept Pharmaceuticals defied gravity again on Friday, surging another 50% in morning trading. Intercept is flying high after positive results on a ...
    






Who Got Rich This Week: Blue Jackets Owner and Married Japanese Biotech Team


Each week at Forbes we scan our database of corporate insiders to see who got richer from the action in the stock market. The Federal Reserve announced this week that it would finally begin to...